The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

© 2024 Drugwatch.com Privacy Policy / Advertising Disclosure / Do Not Sell My Info California Consumer Privacy Act (CCPA) Inquiries Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below. Sorry there was an error. Please wait a moment and try again. Sorry there is a continuing error in our system. Please call us using the phone number listed on this page. Request Type Please select a type:Information RequestData Deletion Full Name Full Name Phone Number Email Street Address Zip Code We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising. Submit

Medicalspares

The BD Alaris PC Unit or Point of Care Unit (PCU) is the “brain” of the pump system. It has a display and keypad on it. It’s what a trained care professional uses to program the pump with a specific amount of medicine to deliver into a patient, when to deliver it and other specific instructions. Some hospitals or facilities have pre programmed these settings into the PCU.

The company recalled the devices because one or more keys on the keypad could become stuck or unresponsive. This could prevent clinicians from changing medication or fluid infusions and infusion delay.

On Feb. 4, 2020, BD recalled 774,000 various Alaris series 8000 PCUs and modules. Some of these recalled pumps were distributed as far back as July 2004.

Medical equipmentsparepartssuppliers India

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

On May 6, 2019, BD recalled 151,139,816 Alaris Pump Model 8100 infusion sets manufactured between May 2016 and March 2019. The pumps could deliver medications too quickly or deliver medications while the pump was not in “running status.”

We aim to hold individual units in stock as well as a wide range of accessories and spare parts to complement your chosen unit.

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

The Auto-ID Module allows providers to scan barcodes that provide information such as the patient ID, clinician ID and drug information. This information goes into the PCU.

On Aug. 4, 2020, BD recalled 305,526 BD Alaris PC Unit 8015 models and keypad replacement kits manufactured from April 7, 2017 to June 15, 2020.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

MedicalAccessories

The FDA classified this as a class one recall — the agency’s most severe. This means the devices can cause serious injuries or death.

Modules can be attached to either side of the PCU. These modules perform a variety of tasks from dispensing medication to stopping medication at specific times.

Medical partsand supplies

Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

Join our newsletter to stay up to date on dangerous drugs and devices, keep up on lawsuit and settlement news, learn about FDA recalls, and more.

At the time of the announcement, BD was aware of 1,186 complaints and one reported injury. At the time, there were no reported deaths.

Medical equipmentspareparts

Several recalls of BD Alaris pumps sold in the United States have occurred over the years. The most recent recalls occurred in 2019 and 2020. The recalled models include PCUs, modules and accessories from the 8000 series.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

Drugwatch.com writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

Keep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.

BD determined that the thickness of silicone segments of the tubing was not uniform. This could cause the tubing to fail or become blocked. The recall was associated with reports of injuries, some of which were serious.

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations. Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews. The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals. About Drugwatch.com Assisting patients and their families since 2008. Helped more than 12,000 people find legal help. A+ rating from the Better Business Bureau. 5-star reviewed medical and legal information site. Learn More About Us Testimonials "Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her." Marianne Zahren Patient’s Family Member

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

Alaris infusion pumps come with a PCU, or point of care unit, and can be customized with up to four modules. These modules are connected to tubes and bags of medicine or other fluids. The modules work together with the PCU to perform a variety of functions.

Becton, Dickinson and Company (BD) manufactures the BD Alaris Systems pumps. The U.S. Food and Drug Administration allowed the first models onto the market in the 1990s. The agency has since cleared more models for sale.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

MGE manufactures the SAM range of Medical Suction equipment. Designed and manufactured in the UK they are used extensively throughout the World in hospital wards and theatres, surgeries, clinics, ambulances and also in Homecare.

BD has issued several recalls for these pumps and pump modules because of software and hardware problems that can cause serious injuries and death.

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

Medicalsparepartssuppliers

Health care professionals use the BD Alaris pump module for large volume infusions in pediatric, neonatal or adult patients. Up to four of these modules can attach to the PCU and dispense four different infusions.

This module helps ensure accurate medication delivery. It works with various syringe sizes and provides a wide range of flow rates.

A 2022 report noted that up to 75% of IV pumps have vulnerabilities that could threaten patient safety if exploited. Because these defects may cause serious injuries or death, lawyers are filing BD Alaris Systems lawsuits on behalf of patients injured after using these pumps.

Medical partsname

Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.

MG Electric (Colchester) Ltd, Wyncolls Road, Severalls Business Park, Colchester, Essex, CO4 9HY UNITED KINGDOM T. +44 (0)1206 842244   F. +44 (0)1206 845849   E. sales@mgelectric.co.uk

The Alaris EtCO2 Module helps reduce the risk of opioid-induced respiratory depression. It monitors a patient’s respiratory status and stops medicine infusion if the respiratory status falls. Providers can use this module with the PCU or on its own.

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations. Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews. The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals. About Drugwatch.com Assisting patients and their families since 2008. Helped more than 12,000 people find legal help. A+ rating from the Better Business Bureau. 5-star reviewed medical and legal information site. Learn More About Us Testimonials "Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her." Marianne Zahren Patient’s Family Member

Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.

Medical equipmentAccessories

The Syringe Module delivers medications, fluids, blood products and blood. The flow of medication is continuous or intermittent.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

BD Alaris Systems infusion pumps monitor a patient’s vital signs and deliver medications, blood and fluids into a patient’s body in controlled amounts. Health care facilities and hospitals use these pumps in adults and children.

On Aug. 4, 2020, BD issued a recall for 141,889 of its syringe modules and size sensor kits because PCU units may display the wrong syringe type or size. This could lead to over or under infusion.

Hospitals and health care facilities across the country use these pumps to deliver nutrients, blood products and medications such as insulin, antibiotics, chemotherapy and pain relievers. Trained users, such as nurses, program these pumps to deliver set quantities of medications and fluids into a patient at specific times.

BD said system errors could lead to over or under infusion and interruption of infusion. At the time of the recall, BD was aware of 55 reported injuries and one death.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.